Hikma Pharmaceuticals PLC (OTCPK:HKMPF)
$ 23.62 0 (0%) Market Cap: 5.26 Bil Enterprise Value: 6.23 Bil PE Ratio: 27.79 PB Ratio: 2.20 GF Score: 93/100

Hikma Pharmaceuticals PLC Meet the Management Event: Injectables Transcript

Mar 24, 2021 / 02:00PM GMT
Release Date Price: $31.13
Sigurdur Oli Olafsson
Hikma Pharmaceuticals PLC - CEO & Executive Director

So good morning, and good afternoon, everyone, and welcome to our new Meet the Management series. I'm Siggi Olafsson, the CEO of Hikma Pharmaceuticals. And today, we will meet the management of our Global Injectable Business.

This is the first in a series of investor events we plan to hold this year. Since we are all exhausted from the long Zoom meetings, we decided to keep these events relatively short, only 90 minutes. And each event will focus on 1 of our 3 businesses. Of course, we would have loved to host you at our facility, but as you understand, that's not possible at the moment.

If we move to the next slide, the safe harbor slide. Before we start, I'd like to remind you and refer you to this slide, the safe harbor statement in front of this presentation.

If we move to the agenda, let's quickly review the agenda. I'll kick things off with a brief introduction to our Injectable business. Riad Mishlawi, the President of the Global Injectables, will then take you through more detailed overview

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot